Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Journal of Gastroenterology
Published in: Journal of Gastroenterology 1/1999

01-01-1999

Refractory hepatic hydrothorax treated with transjugular intrahepatic portosystemic shunt

Authors: Mikako Degawa, Keisuke Hamasaki, Koji Yano, Kazuhiko Nakao, Yuji Kato, Ichiro Sakamoto, Keisuke Nakata, Katsumi Eguchi

Published in: Journal of Gastroenterology | Issue 1/1999

Login to get access
Metadata
Title
Refractory hepatic hydrothorax treated with transjugular intrahepatic portosystemic shunt
Authors
Mikako Degawa
Keisuke Hamasaki
Koji Yano
Kazuhiko Nakao
Yuji Kato
Ichiro Sakamoto
Keisuke Nakata
Katsumi Eguchi
Publication date
01-01-1999
Publisher
Springer-Verlag
Published in
Journal of Gastroenterology / Issue 1/1999
Print ISSN: 0944-1174
Electronic ISSN: 1435-5922
DOI
https://doi.org/10.1007/s005350050228

Other articles of this Issue 1/1999

Journal of Gastroenterology 1/1999 Go to the issue

OriginalPaper

Predictive value of different hepatitis C serological assays in the treatment of chronic hepatitis C with interferon α

OriginalPaper

Laboratory diagnosis of toxigenic Clostridium difficile by polymerase chain reaction: presence of toxin genes and their stable expression in toxigenic isolates from Japanese individuals

OriginalPaper

Effects of "body compression" on parameters related to ascites formation: therapeutic trial in cirrhotic patients

OriginalPaper

Further experiments are necessary to determine whether transjugular intrahepatic portosystemic shunt is the definitive treatment for refractory hepatic hydrothorax

OriginalPaper

Intraductal ultrasonography in six patients with endoscopic biliary stenting

OriginalPaper

Primary hepatic carcinoid tumor
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Heart Failure Video

Year in Review: Heart failure and cardiomyopathies

Watch now

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits